patritumab
Daiichi Sankyo,Amgen
['mbc', 'her3-dxd', 'bcsm']
join me today in hall b1 at 11:30am for #mbc oral abstracts and the results from a recent phase 2 study of her3-dxd in patients with metastatic #bcsm! #asco23 
Med Onc, Director of Breast Cancer Research Program @ Sarah Cannon Research Institute #bcsm #WomenInMedicine Wife, Mom to 2 girls, tweets are mine.